Margaret E. Brousseau

Effects of an Inhibitor of Cholesteryl Ester Transfer Protein on HDL Cholesterol

Margaret E. Brousseau, Ernst J. Schaefer, Megan L. Wolfe et al. · New England Journal of Medicine · 2004 · 777 citations · Full text

Medicine, Cardiology, Pharmacology +13

Effects of Cholesteryl Ester Transfer Protein Inhibition on High-Density Lipoprotein Subspecies, Apolipoprotein A-I Metabolism, and Fecal Sterol Excretion

Margaret E. Brousseau, Margaret R. Diffenderfer, John S. Millar et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2005 · 233 citations

Life Sciences, Pharmacology, Pharmacotherapy +15

Cholesteryl Ester Transfer Protein <b> <i>Taq</i> </b> I B2B2 Genotype Is Associated With Higher HDL Cholesterol Levels and Lower Risk of Coronary Heart Disease End Points in Men With HDL Deficiency

Margaret E. Brousseau, John O’Connor, José M. Ordovás et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2002 · 147 citations

Medicine, Genetics, Molecular Genetics +14

Novel mutations in the gene encoding ATP-binding cassette 1 in four Tangier disease kindreds

Margaret E. Brousseau, Ernst J. Schaefer, Josée Dupuis et al. · Journal of Lipid Research · 2000 · 130 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Polymorphisms in the multidrug resistance-1 (MDR1) gene influence the response to atorvastatin treatment in a gender-specific manner

Kouji Kajinami, Margaret E. Brousseau, José M. Ordovás et al. · The American Journal of Cardiology · 2004 · 121 citations

Life Sciences, Genetics, Pharmacology +11